Evidence map›Paper›PMID 36826284›Full record

ArticleGels (Basel, Switzerland)2023

Poly(Sulfobetaine Methacrylate-co-Vinyl Pyrrolidone) Hydrogels as Potential Contact Lenses Delivery Systems for Timolol Maleate.

Denitsa Nikolova, Christo Tzachev, Lachezar Christov, Elena Vassileva

Open access · goldAbstract read
In one paragraph

Article in Gels (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Denitsa NikolovaLaboratory on Structure and Properties of Polymers, Faculty of Chemistry and Pharmacy, University of Sofia, 1, James Bourchier Blvd., 1164 Sofia, Bulgaria.
Christo TzachevLaboratory of Pharmaceutical Technology, Faculty of Chemistry and Pharmacy, University of Sofia, 1, James Bourchier Blvd., 1164 Sofia, Bulgaria.
Lachezar ChristovLaboratory on Water Soluble Polymer, Polyelectrolytes and Biopolymers, Faculty of Chemistry and Pharmacy, University of Sofia, 1, James Bourchier Blvd., 1164 Sofia, Bulgaria.
Elena VassilevaLaboratory on Structure and Properties of Polymers, Faculty of Chemistry and Pharmacy, University of Sofia, 1, James Bourchier Blvd., 1164 Sofia, Bulgaria.ORCID 0000-0002-0566-5883
Sofia University "St. Kliment Ohridski" · BG

Funding

Bulgarian National Science Fund KP-06-DO02/2-08.07.2021
6 · The paper itself

Abstract

The study reveals the development of novel hydrogels based on sulfobetaine methacrylate (SB) and vinyl pyrrolidone (VP) copolymers as potential contact lenses delivery systems of timolol maleate (TM). The novel copolymer networks demonstrated composition dependent swelling kinetics, where the hydrophilicity of VP and the physical network of SB monomeric units play significant roles. TM loading efficiency appeared to slightly depend on the copolymeric composition, increasing upon VP monomeric unit increase. In contrast, the TM release was prolonged when the SB monomeric units content in the copolymers increased, reaching full drug release for 48 h for the SB-rich networks. The transparency of the hydrogels was also studied and the obtained values demonstrate their applicability as potential materials for soft contact lenses. The study has revealed the potential of these novel copolymeric hydrogels as materials for contact lenses delivery systems of timolol maleate.

Indexed as

contact lenses drug deliverycopolymerspoly(sulfobetaine methacrylate)poly(vinyl pyrrolidone)timolol maleate

Identifiers

PMID36826284
PMCPMC9956182
OpenAlexW4318480763

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.